Cardiac Glycosides sales in Germany have seen a significant decline from 2013 to 2023. The year-on-year variation indicates consistent decreases, with notable drops in 2015 (-23.1%), 2019 (-9.35%), and 2022 (-12.62%). The last reported CAGR for the period ending in 2023 is -8.13%. Future trends forecast a continued decline, with an expected 5-year CAGR of -22.39% and overall sales dropping from $16.1 million in 2023 to $3.8 million by 2028.
Future Trends to Watch: Observing this steep downward trajectory, it is crucial to monitor advancements in alternative medication, shifts in treatment protocols, and regulatory changes affecting cardiac glycosides' market dynamics.
